2010 |
Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. |
Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD |
2008 |
Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2022 |
Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies. |
Mohab M. Ibrahim, PhD, MD, Laurent F Martin |
2004 |
Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. |
|
2015 |
Perimenopause as a neurological transition state. |
Roberta Diaz Brinton, Ph.D, Fei Yin, Ph.D. |
2018 |
Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. |
Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2006 |
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161. |
|
2017 |
Pharmacokinetics and safety profile of single-dose administration of an estrogen receptor β-selective phytoestrogenic (phytoSERM) formulation in perimenopausal and postmenopausal women. |
Roberta Diaz Brinton, Ph.D |
2014 |
Physiological temperatures drive glutamate release onto trigeminal superficial dorsal horn neurons. |
Tally Largent-Milnes, PhD |
2015 |
Postmenopausal hormone therapy, type 2 diabetes mellitus, and brain volumes. |
Roberta Diaz Brinton, Ph.D |
2015 |
Potency enhancement of the κ-opioid receptor antagonist probe ML140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif. |
John M. Streicher, PhD |
2020 |
Potential therapeutic treatments of cancer-induced bone pain. |
Todd Vanderah, PhD |
2013 |
Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. |
Roberta Diaz Brinton, Ph.D |
2022 |
Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache. |
Trent Anderson, Edita Navratilova, Frank Porreca, PhD |
2010 |
Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. |
John M. Streicher, PhD |
2007 |
Profiling of selenomethionine responsive genes in colon cancer by microarray analysis. |
|
2008 |
Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. |
Roberta Diaz Brinton, Ph.D |
2009 |
Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. |
Roberta Diaz Brinton, Ph.D |
2008 |
Progesterone receptors: form and function in brain. |
Roberta Diaz Brinton, Ph.D |
2004 |
Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. |
John M. Streicher, PhD |
2022 |
Radiocaine: An Imaging Marker of Neuropathic Injury. |
Tally Largent-Milnes, PhD |
2015 |
Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. |
Jeffrey J. Lochhead, PhD |
2017 |
Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics. |
Frank Porreca, PhD |
2010 |
Recently patented and promising ORL-1 ligands: where have we been and where are we going? |
Tally Largent-Milnes, PhD, Todd Vanderah, PhD |
2022 |
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. |
Nam Lee, Ph.D. |